⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 13, 2024Journal of Dental SciencesOpen Access

The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas

Shi-Rou Chang Chung‐Hsien Chou Hsi‐Feng Tu Chung‐Ji Liu Kuo-Wei Chang Shu‐Chun Lin

View Full Paper

Ask AI

Bookmark

Share

Abstract

T cells require second immune checkpoint molecules for activation and immune memory after antigen presentation. We found that inducible co-stimulator (ICOS) has been a favorable prognostic factor amongst B7 immune checkpoint co-stimulators (ICSs) families in head and neck squamous cell carcinoma (HNSCC) and oral SCC (OSCC).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chang et al. (2024) studied this question.

synapsesocial.com/papers/68e6a4ffb6db64358762871e https://doi.org/10.1016/j.jds.2024.05.004

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The high expression of immune checkpoint co-stimulators predicts a favorable prognosis in head and neck carcinomas2024
2Radiomics signatures based on computed tomography for noninvasive prediction of ICOS expression and prognosis in head and neck squamous cell carcinomaOriginal Research · 2026
3Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule2024 · 2 citations
4Co-Stimulatory and Immune Checkpoint Molecule Expression on Peripheral Immune Cells Differs Age Dependently Between Healthy Donors and Patients with Head and Neck Squamous Cell Carcinoma2025 · 2 citations
5Characterization of the immune microenvironment in a 3D organotypic co-culture model for HNSCC2024